Tuberculosis is a global emergency, and rich nations should treat it as such

The science to develop a new vaccine is available. A lack of funding is all that hinders progress on health equity.

While COVID vaccines have brought attention to disparities in access, tuberculosis vaccines continue to expose disparities in the kinds of diseases for which vaccines are created, writes Nayanika Ghosh.Unsplash photograph by Julia Koblitz

Opinion

BY NAYANIKA GHOSH

July 17, 2023

We saw the capacity for human ingenuity with the development of at least a dozen life-saving vaccines in less than two years following the declaration of the COVID-19 pandemic. But this shone a light on who had priority regarding vaccine access, and those living in poverty w...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy